The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.80
Bid: 17.80
Ask: 18.70
Change: -0.10 (-0.54%)
Spread: 0.90 (5.056%)
Open: 17.60
High: 17.80
Low: 17.60
Prev. Close: 18.35
LMS Live PriceLast checked at -
LMS Capital is an Investment Trust

To achieve absolute total returns over the medium to longer term, principally through capital gains and supplemented with the generation of a longer term income yield, by investing primarily in private equity.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Quarter 2022 Update

27 Apr 2022 07:00

RNS Number : 4473J
LMS Capital PLC
27 April 2022
 

 

 

 

 

 

 

27 April 2022

 

 

LMS CAPITAL PLC

First Quarter 2022 Update

 

 

LMS Capital plc (the "Company"), a listed Investment Company, provides the following update covering the three months ended 31 March 2022.

 

Financial Highlights

 

· Unaudited Net Asset Value ("NAV") at 31 March 2022 was £50.3 million (62.3p per share). This compares to £49.1 million (60.8p per share) at 31 December 2021;

· Unrealised portfolio gains of £1.3 million, including foreign exchange gains, and accrued interest income of £0.3 million from the Dacian Petroleum investment; and

· Cash at 31 March 2022 was £19.5 million compared to £20.1 million at 31 December 2021.

 

Unaudited Net Asset Value at 31 March 2022

 

The £1.2 million increase in NAV during the first quarter is comprised of the following:

· Unrealised gains of £0.6 million on the mature investment portfolio;

· Accrued interest income of £0.3 million on the Dacian Petroleum investment;

· £0.7 million of portfolio and £0.1 million of non-portfolio foreign exchange gains from the strengthening of the U.S. Dollar against sterling; and

· £0.4 million of running costs and £0.1 million of investment related costs.

 

 

 

 

The 31 March 2022 NAV is summarised below:

 

 

Unaudited

Audited

 

31 March

2022

31 December

 2021

 

£ 000s

Mature Investment Portfolio

 

 

Quoted Investments

297

383

Unquoted Investments

9,078

8,668

Funds

14,755

13,929

 

24,130

22,980

New Investment Portfolio

 

 

Quoted Investments

-

-

Unquoted Investments

8,470

7,958

Funds

-

-

 

8,470

7,958

 

 

 

Total Investments

32,600

30,938

Cash

19,458

20,113

Other Net Assets/Liabilities 

(1,746)

(1,942)

Net Asset Value

50,312

49,109

 

The NAV at the end of March is based on the valuation of the Company's investments as at 31 December 2021, adjusted for transactions in the three months ended 31 March 2022, price movements on quoted securities, movements in foreign currency exchange rates, cash calls and distributions from funds, and the latest information available from third party fund managers.

 

Portfolio Unrealised Net Gains

 

The portfolio net unrealised gains of £0.6 million and £0.3 million of accrued interest income, excluding foreign exchange movements, are summarised below:

 

Quoted Investments

 

The Company's quoted investment valuations decreased by a net £0.1 million during the first quarter of 2022, reflecting underlying market price decreases.

 

Unquoted Investments

 

The Company's unquoted investments include our direct holdings in Dacian Petroleum, Medhost and Elateral, assets managed by San Francisco Equity Partners (ICU Eyewear and YesTo), and a convertible debt instrument with IDE Group Holdings.

 

Total unquoted investment unrealised gains were nil during the first quarter as a £0.1 million gain in Medhost was offset by a £0.1 million loss in Elateral.

 

Dacian Petroleum had £0.3 million in investment accrued interest income during the first quarter.

 

Funds

 

The Company's fund investments include its holding in Brockton Capital Fund I, Opus Capital Venture Partners, Weber Capital Partners and five other smaller fund interests.

 

Fund unrealised net gains were £0.7 million. The principal movements were:

· Opus Capital Venture Partners - Unrealised gain of £1.1 million, driven by a significant uplift in the fund manager's valuation of one of the Fund's two principal remaining investments;

· Brockton Capital Fund 1 - Unrealised gain of £0.4 million, reflecting the unwinding of the discount rate as the investment is valued on a discounted cash flow basis;

· Eden - Unrealised loss of £0.4 million;

· Weber Capital Partners - unrealised loss of £0.3 million due to the performance in the U.S. microcap equities held in the fund; and

· Other unrealised losses on funds of £0.1 million.

 

The carrying value of the funds is based on the latest available information from the respective fund managers, generally the 31 December 2021 fund valuation reports except for Weber Capital Partners, which is based on 31 March 2022 valuations.

 

Portfolio Realisations

 

There were fund distributions of £0.1 million during the first quarter.

 

Liquidity and Outlook

 

The Company continues to maintain significant cash balances, £19.5 million at 31 March 2022. The Board is reviewing a number of opportunities with its real estate team, as well as further investment opportunities, but continues to take a cautious stance in the way the company's resources are deployed.

 

 

 

 

 

For further information please contact:

LMS Capital PLC

Nick Friedlos, Managing Director

0207 935 3555

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFIFMLTMTTTBTT
Date   Source Headline
2nd Mar 20214:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:36 pmRNSPrice Monitoring Extension
2nd Feb 20217:00 amRNSNAV and Portfolio Update
7th Jan 20211:59 pmRNSPortfolio Update
4th Dec 20204:41 pmRNSSecond Price Monitoring Extn
4th Dec 20204:36 pmRNSPrice Monitoring Extension
28th Oct 20207:00 amRNSNet Asset Value(s) 3rd Quarter 2020 update
12th Aug 20207:00 amRNSPortfolio Update
4th Aug 20209:59 amRNSHalf-year Report
25th Jun 20207:13 amRNSResults of 2020 Annual General Meeting
28th May 20201:01 pmRNSAccounts and Notice of AGM
26th May 20207:00 amRNSDISCLOSURE OF RIGHTS ATTACHED TO LISTED SECURITIES
13th May 20204:00 pmRNSHolding(s) in Company
13th May 20203:37 pmRNSDirector/PDMR Shareholding
30th Apr 202012:51 pmRNSDirector/PDMR Shareholding
29th Apr 20207:00 amRNS1st Quarter 2020 Update
15th Apr 202011:32 amRNSFinal Results
31st Mar 202012:08 pmRNSSecond Price Monitoring Extn
31st Mar 202012:03 pmRNSPrice Monitoring Extension
31st Jan 202011:31 amRNSEntry in the register of small registered UK AIFMs
30th Jan 202010:21 amRNSCompany Update and NAV Estimate as at 31 Dec 2019
20th Dec 20193:45 pmRNSDirector/PDMR Shareholding
12th Dec 20192:38 pmRNSSpecial Interim Dividend
29th Nov 20198:04 amRNSDirectorate Changes & Inv Management Arrangements
28th Nov 201912:42 pmRNSResult of GM& Resignation of Independent Directors
19th Nov 20199:32 amRNSProxy Form Relating to General Meeting on 28 Nov19
5th Nov 201912:45 pmRNSPublication of Circular &Notice of General Meeting
5th Nov 201912:07 pmRNS3rd Quarter 2019 update
27th Sep 20197:00 amRNSUpdate on investment management arrangements
14th Aug 20197:00 amRNSSale of investment in Entuity completes
2nd Aug 201912:30 pmRNSResults for the six months ended 30 June 2019
26th Jul 201910:30 amRNSReview of investment management arrangements
4th Jun 20199:00 amRNSResult of AGM
30th Apr 20197:00 amRNSNotice of AGM
30th Apr 20197:00 amRNS1st Quarter 2019 update
22nd Mar 20197:00 amRNSPreliminary Results
29th Jan 20197:00 amRNSNet Asset Value(s)
12th Nov 20187:00 amRNSTransaction notification
12th Nov 20187:00 amRNSTransaction notification
9th Nov 20185:48 pmRNSTR-1: Notification of major holdings - Replacement
9th Nov 20185:46 pmRNSTR-1: Notification of major holdings - Replacement
9th Nov 20182:31 pmRNSTR-1: Notification of major holdings
9th Nov 20182:29 pmRNSTR-1: Notification of major holdings
30th Oct 20187:00 amRNSThird quarter update
12th Sep 20181:15 pmRNSHalf-year Report
31st Jul 20187:00 amRNSNAV Estimate at 30 June 2018 and Sale of Penguin
13th Jun 20189:50 amRNSSale of Penguin
1st Jun 20187:00 amRNSHolding(s) in Company
1st Jun 20187:00 amRNSExercise of Warrants
1st May 20185:35 pmRNSAuthorisation of Gresham House AM as AIFM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.